Disclosure of Management Transaction
Disclosure of Management Transaction according to the Art. 19 of Regulation (ΕU) No. 596/2014
Peania, 20 March 2023 – Lavipharm S.A. (hereinafter referred to as «Lavipharm»), pursuant to article 19 of Regulation (EU) No. 596/2014, and following a relevant notification, announces that Mr. Vasileios Baloumis, Group CFO:
-on 16 March purchased 15,000 common shares of Lavipharm, of a total value of EUR 5,758.49 and
Announcement 1795/2023 (no English translation available)
This Announcement is available only in Greek.
Announcement 1793/2023 (no English translation available)
This Announcement is available only in Greek.
Announcement 1792/2023 (no English translation available)
This Announcement is available only in Greek.